
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy individuals: results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Author(s) -
Leonardo Santos Hoff,
Samuel Katsuyuki Shinjo,
R Naveen,
Jessica Day,
Parikshit Sen,
Jucier Gonçalves,
James B Lilleker,
Mrudula Joshi,
Vishwesh Agarwal,
Sinan Kardeş,
MinChul Kim,
Marcin Milchert,
Ashima Makol,
Tamer A. Gheita,
Babur Salim,
Tsvetelina Velikova,
Abraham Edgar GraciaRamos,
Ioannis Parodis,
Albert Selva-O’Callaghan,
Eleikiphorou,
Ai Lyn Tan,
Tulika Chatterjee,
Lorenzo Cavagna,
Miguel Ángel Saavedra,
Nelly Ziadé,
Johannes Knitza,
Masataka Kuwana,
Albert Selva-O’Callaghan,
Oliver Distler,
Hector Chinoy,
Vikas Agarwal,
Rohit Aggarwal,
Latika Gupta,
COVAD Study Group
Publication year - 2022
Publication title -
xxxix congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2022.1905
Subject(s) - medicine , covid-19 , vaccination , immunology , virology , disease , outbreak , infectious disease (medical specialty)